Enabling innovation in cell and gene therapy
In the news
ART-TG is an innovation and development laboratory for cell and gene therapy, established by Inserm. Its mission is to accelerate the transfer of promising research discoveries towards clinical stages, which ultimately will ensure that the best gene therapies will be available for patients.
Anne Galy, founder of ART-TG (view her bio)
ART-TG is a founding member of the MAGENTA industrial integrator, established by the French government to address the challenges of industrial production of biomedecines.
Anne Galy PhD
Business Developer :